| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA300053
Max Phase: Preclinical
Molecular Formula: C11H15N3
Molecular Weight: 189.26
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1ccc(NCC2=NCCN2)cc1
Standard InChI: InChI=1S/C11H15N3/c1-9-2-4-10(5-3-9)14-8-11-12-6-7-13-11/h2-5,14H,6-8H2,1H3,(H,12,13)
Standard InChI Key: DUWYZPORHIKSDF-UHFFFAOYSA-N
Associated Targets(non-human)
Alpha-2a adrenergic receptor 162 Activities
Adrenergic receptor alpha-2 3313 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Adrenergic receptor alpha-1 5652 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 189.26 | Molecular Weight (Monoisotopic): 189.1266 | AlogP: 1.41 | #Rotatable Bonds: 3 |
| Polar Surface Area: 36.42 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 9.33 | CX LogP: 1.03 | CX LogD: -0.78 |
| Aromatic Rings: 1 | Heavy Atoms: 14 | QED Weighted: 0.75 | Np Likeness Score: -0.98 |
References
| 1. Saari WS, Halczenko W, Randall WC, Lotti VJ.. (1983) alpha-Adrenergic activities of some substituted 2-(aminomethyl)imidazolines., 26 (12): [PMID:6139481] [10.1021/jm00366a022] |
Source
Source(1):